WHO adds two new vaccines to Ebola trials in DR Congo

The World Health Organization has announced the addition of two new vaccines to ongoing clinical trials in the Democratic Republic of Congo, as part of efforts to contain the Ebola outbreak caused by the Bundibugyo virus.

The organization said the vaccines were developed by the University of Oxford in collaboration with the Serum Institute of India and Moderna.

The WHO noted that these will be the first vaccines specifically designed to target the Bundibugyo virus responsible for the current Ebola outbreak.